Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

New-tech Town Hall date set: The severe snowstorms that hit the mid-Atlantic region earlier this month led CMS to reschedule the New-Technology Town Hall meeting, originally set for Feb. 10 in Baltimore, to Friday, Feb. 19. CMS plans to make a call-in phone number available on its Web site. The annual meeting gives device makers a chance to prove whether the products named in their applications for new-technology add-on payments offer substantial clinical improvement over existing technology. Four device makers have applied for 2011 new-tech add-on payments: Monteris Medical, InfraReDx, Zimmer and Nycomed Austria (1"The Gray Sheet" Dec. 14, 2009). A New Technology Informational Workshop, also scheduled for Feb. 10, was cancelled indefinitely

You may also be interested in...



Four Device Makers Apply For 2011 New-Technology Add-On Bonus

CMS has received five applications from four device firms for its next round of new-technology add-on payments, including submissions for two products that did not qualify for the extra payment during previous attempts

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel